Dynavax Technologies Corp (NASDAQ: DVAX) has reported earnings for its second fiscal quarter (ending June 30) of $0.09 versus $0.03 for the same period a year ago — an increase of 200%. Relative to the consensus estimate of $0.07, this was a premium of $0.02. For the latest four quarters through June 30, E.P.S. were $0.13 compared to $0.87 a year ago — a decline of -85%.
Recent Price Action
Dynavax Technologies Corp (NASDAQ: DVAX) stock closed at $10.05 on 8/6/24 after a slight decline of -0.2%. Trading volume in this decline was normal. The stock has been extremely weak relative to the market over the last nine months and has declined -13.1% during the last week.
Current PriceTarget Research Rating
DVAX is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Dynavax Technologies has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Dynavax Technologies has a neutral Appreciation Score of 50 and a slightly negative Power Rating of 33, resulting in the Negative Value Trend Rating.
Rating Review
In light of this new information and negative market action we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment